Trial intelligence / Profile preview

Anaesthetic value of S-ketamine in thoracic surgery

ChiCTR2100047144Phase 4Recruiting

Sponsor
Shaoxing Central Hospital
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine (2 arms), sponsored by Shaoxing Central Hospital. Primary endpoints: Analgesia, Sufentanil dosage and 1 more. Started Jun 2021; status: recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2100047144.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047144.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call